Research and Markets (http://www.researchandmarkets.com/research/abda33/microneedles_in_me) has announced the addition of the “Microneedles in Medicine – Technology, Markets and Prospects” report to their offering.
Advances in the processing of materials on a micro-scale have led to the development and introduction of devices that employ very small needles – microneedles – that have significant potential in devices for diagnostics, healthcare monitoring and drug delivery by mechanically perforating the outer skin layer and allowing for transdermal drug absorption or fluid sampling. These processing techniques incorporate one or more technologies that enable the precise machining, extrusion, casting, and/or forming of from one to an array or grid of microneedles. Several factors – include an aging patient population, biological drug therapies for chronic conditions, and an emphasis on patient self-monitoring and self-care – are driving an evolution in the way that healthcare is delivered. Evolving microneedle systems will be well-positioned to address a significant segment of the large -molecule biological drugs expected to emerge from the convergence of automated discovery and genome mapping. Before microneedles find widespread use, researchers must perfect the techniques for optimally inserting them into the skin, and complete the integration of microneedles into a full diagnostic, monitoring or drug delivery system.
Microneedle Technology and Minimally Invasive Medicine:
Advances in the processing of materials on a microscale have led to the development and introduction of devices that employ very small needles – microneedles – that have significant potential in devices for diagnostics, healthcare monitoring and drug delivery by mechanically perforating the outer skin layer and allowing for transdermal drug absorption or fluid sampling. These processing techniques incorporate one or more technologies that enable the precise machining, extrusion, casting, and/or forming of from one to an array or grid of microneedles.
Several factors – include an aging patient population, biological drug therapies for chronic conditions, and an emphasis on patient self-monitoring and self-care – are driving an evolution in the way that healthcare is delivered. Evolving microneedle systems will be well positioned to address a significant segment of the large -molecule biological drugs expected to emerge from the convergence of automated discovery and genome mapping. Before microneedles find widespread use, researchers must perfect the techniques for optimally inserting them into the skin, and complete the integration of microneedles into a full diagnostic, monitoring or drug delivery system.
Market Data
The study presents qualitative and quantitative data and information on key market measures and benchmarks:
– Microneedle Market
– Segment Analysis
– Market Dynamics and
– Sensitivities
– Microneedle
– Technology Economic
– Factors
– Technology Enablers
– Development Status
– Commercial Strategies
– Third-party Stakeholders
– Market Participant
– Profiles
– Device-Pharma Alliance
– Activity and Deal
– Structure
– Competitive Risks
– Proprietary Technology
– User Issues
– Technology Risk Factors
– Regulatory Risk Factors
Forecasts and projections cover the period from 2007 to 2010.
Feature Summary
– Analyzes and evaluates microneedle technology and product research and development, and assesses the medical market potential for existing and probable future products
– Analyzes proprietary technologies and market development issues
– Provides detailed descriptions of medical microneedle business opportunities, market demographics, and business strategies
– Charts product sales data, market share, and forecasts to 2010
– Profiles microneedle medical product and technology participants, their activities, business strategies, and corporate alliances and affiliations
– Assesses the importance of licensing, alliances and partnerships on the success of medical applications for microneedles
– Evaluates the impact of economic, technology, and regulatory factors on the commercial potential of microneedle systems
Key Topics Covered:
Executive Summary
Microneedle Medical Market Overview
– The Trend to Minimally Invasive Medicine
– Drug Delivery & Self-Administration
– Continuous & Remote Monitoring
– Shifting Patient Demographics
– Managed Care Initiatives
– Commercial Microneedle Devices
– Competitive Landscape
Microneedle Design & Technology
– Solid Microneedles
– Hollow Microneedles
– Coated Microneedles
– Microneedle Arrays & Array Geometries
– Microneedle Manufacturing
– Material Selection Issues
– Fabrication Techniques
– Emerging Fabrication Methods
Markets for Microneedle Technology
– Biosensing
– Sampling
– Drug Delivery
– Tissue Enhancement
Microneedle Technology Transfer Factors
– Europe
– Japan
– North America
– Selected Research Programs
Microneedle Market Drivers
– Drug Discovery Trends
– Continuous Monitoring
– Large-Molecule Biologics
– Remote Patient Care
– Patient/Consumer Sentiment
– Enhanced Compliance
Commercial Therapeutic Opportunities
– Cancer Therapeutics
– Dermatology/Cosmetic Surgery
– Diabetes
– Diagnostics
– Fertility
– Genetic Engineering
– Pain Management
– Therapeutic Proteins/Peptides
– Vaccines
– Emerging Markets
Market Factors
– Regulatory
– FDA
– EMEA
– Pharma & Medical Devices Agency
Microneedle Company Profiles
For more information visit http://www.researchandmarkets.com/research/abda33/microneedles_in_me
Comments